Skip to main content
Retour
Watch Compare

WINDTREE THERAPEUTICS INC /DE/

Qualité des données : 83%
WINT
OTC Manufacturing Chemicals
0,01 €
▼ 0,00 € (-19,78%)
6 months return
—
Momentum
Neutral
Free cash flow
-15,12 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-519,54%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,33
Interest Coverage-68,64

Valorisation

PE (TTM)
-0,01
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -15,12 M

Price History

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Surprises de Résultats

EPS
Reported Estimate
Q12024 Q22024 Q32024 Q42024
Reported 1 099,00 € -1 045,50 € -211,50 € —
Estimate — -405,50 € -113,50 € -39,00 €
Surprise — -157,83% -86,34% —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -39,99 M
ROE N/A ROA -167,31%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -15,12 M
ROIC -519,54% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0,33
Debt / Equity N/A Current Ratio 0,33
Interest Coverage -68,64 Asset Turnover N/A
Working Capital -14,70 M Tangible Book Value -11,61 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,01 · EV/EBITDA: N/A
P/E Ratio -0,01 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3834,00%
Market Cap 394 392,0 Enterprise Value 190 392,0

Per Share

EPS: N/A · FCF/Share: -0,46
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0,46 OCF / Share -0,46
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 37,81% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 37,81%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -1,79 M -20,29 M -39,21 M -67,64 M -32,57 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -26,14 M -20,60 M -41,33 M -77,28 M -30,32 M
EBITDA — — — — —
R&D Expenses 16,28 M 8,34 M 11,10 M 17,79 M 15,37 M
SG&A Expenses 8,74 M 9,20 M 10,79 M 14,47 M 14,94 M
D&A — — — — —
Interest Expense 235 000,0 50 000,0 53 000,0 114 000,0 125 000,0
Income Tax -6 000,0 0,0 -1,37 M -9,99 M —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 27,88 M 32,41 M 37,95 M 74,79 M 112,89 M
Total Liabilities 14,70 M 29,02 M 27,94 M 32,91 M 43,33 M
Shareholders' Equity 10,00 M 3,39 M 10,01 M 41,88 M 69,55 M
Total Debt — — — — —
Cash & Equivalents 1,78 M 4,32 M 6,17 M 22,35 M 16,93 M
Current Assets 2,57 M 5,38 M 7,38 M 23,49 M 18,12 M
Current Liabilities 5,72 M 4,00 M 2,46 M 4,92 M 6,13 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E 0,0 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3